Literature DB >> 15341192

Nitric oxide and brain hyperexcitability.

Giuseppe Ferraro1, Pierangelo Sardo.   

Abstract

Nitric oxide (NO) is a gaseous messenger involved in atypical forms of intercellular communications, able to exert a strong functional modulation of several neurotransmitter systems. In particular, NO heavily influences the excitatory neurotransmitter glutamate, mainly through NMDA receptors, and the inhibitory neurotransmitter GABA, mainly through GABA A receptors. Due to the involvement of glutamate and GABA in a delicate balance conditioning the functional status of the neural cells, this interaction suggests a role for NO in regulating neuronal excitability and its transition towards hyperexcitability phenomena. This article reviews the main knowledge about the relationships existing between the activity of the NO system and the experimental aspects of epilepsy, focusing on the somewhat antithetic findings about the proconvulsant or the anticonvulsant roles exerted by nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341192

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  16 in total

1.  Nitric oxide production in the perifornical-lateral hypothalamic area and its influences on the modulation of perifornical-lateral hypothalamic area neurons.

Authors:  A Kostin; S Rai; S Kumar; R Szymusiak; D McGinty; M N Alam
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  The acute antinociceptive effect of HBO₂ is mediated by a NO-cyclic GMP-PKG-KATP channel pathway in mice.

Authors:  Lindsay P Quock; Yao Zhang; Eunhee Chung; Yusuke Ohgami; Donald Y Shirachi; Raymond M Quock
Journal:  Brain Res       Date:  2010-10-25       Impact factor: 3.252

3.  Nitric oxide-mediated central sympathetic excitation promotes CNS and pulmonary O₂ toxicity.

Authors:  Ivan T Demchenko; Alexander N Moskvin; Alexander I Krivchenko; Claude A Piantadosi; Barry W Allen
Journal:  J Appl Physiol (1985)       Date:  2012-03-22

4.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

5.  The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells.

Authors:  Parijat Kabiraj; Carlos A Valenzuela; Jose E Marin; David A Ramirez; Lois Mendez; Michael S Hwang; Armando Varela-Ramirez; Karine Fenelon; Mahesh Narayan; Rachid Skouta
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

6.  Lamotrigine differently modulates 7-nitroindazole and L-arginine influence on rat maximal dentate gyrus activation.

Authors:  P Sardo; S D'Agostino; F Carletti; V Rizzo; V La Grutta; G Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

7.  The role of nitric oxide in homocysteine thiolactone-induced seizures in adult rats.

Authors:  Dragan Hrncić; Aleksandra Rasić-Marković; Danijela Krstić; Djuro Macut; Dragan Djuric; Olivera Stanojlović
Journal:  Cell Mol Neurobiol       Date:  2009-08-28       Impact factor: 5.046

8.  In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.

Authors:  Pierangelo Sardo; Stefania D'Agostino; Valerio Rizzo; Fabio Carletti; Gioacchino Lonobile; Giuseppe Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

9.  Antagonism of the antinociceptive effect of nitrous oxide by inhibition of enzyme activity or expression of neuronal nitric oxide synthase in the mouse brain and spinal cord.

Authors:  Jessica Lack Cope; Eunhee Chung; Yusuke Ohgami; Raymond M Quock
Journal:  Eur J Pharmacol       Date:  2009-10-08       Impact factor: 4.432

Review 10.  TRPV4 and the regulation of vascular tone.

Authors:  Jessica A Filosa; Xiaoqiang Yao; Geraldine Rath
Journal:  J Cardiovasc Pharmacol       Date:  2013-02       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.